@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0013227 "drug"; ns1:C0597357 "receptors"; ns1:C1167395 "host"; ns1:C1254351 "drug"; ns1:C3245505 "potential"; ns1:C4527371 "candidate"; ns1:C5203670 "COVID-19" . rdf:predicate ns3:TRIPLE_UID:ggiljvum-TRIPLE-ABSTRACT-16 "bind" . rdf:subject ns1:C0011777 "dexamethasone"; ns1:C0011816 "Dex" . rdfs:Triple-UID ns2:TRIPLE_UID:ggiljvum-TRIPLE-ABSTRACT-16 "ggiljvum-TRIPLE-ABSTRACT-16" . rdfs:sentence rdfs:label "The study demonstrates that dexamethasone (Dex) could bind to both the viral and host receptors as a potential drug candidate for COVID-19." . rdfs:triple rdfs:label "dexamethasone ( Dex ) bind to both the viral and host receptors as a potential drug candidate for COVID-19" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:45:45.370025"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "E/z65HluM5Whqq52fZE6t0XncvBa40HN+dwjPyKTNkAX9Q1XHhbruQXlY+Ek2v8wnZZ2qt0LO13vTkYcLUPX8+fYC2vxHESWMOudQfku9wjbiJ4gKvNuq0nIDbIMDVnq9GirbiA4OeNlo3cdfyAXjM99PN7UFEerNqNiCrkVW4I="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:45:45.370025"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }